| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/20/2002 | CN1336930A Bridged heterocyclic derivatives |
| 02/20/2002 | CN1336921A Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/20/2002 | CN1336919A Phenylphenanthridines with PDE-IV inhibiting activity |
| 02/20/2002 | CN1336915A Urea of N-heterocyclic carboxylic acid or the isostere of carboxylic acid and aminocarboxylic acid ester |
| 02/20/2002 | CN1336826A Whitening compositions for oral administration |
| 02/20/2002 | CN1336817A Topical composition comprising N-acetylaldosamines or N-acetylamino acids |
| 02/20/2002 | CN1336231A Burn treaitng external-use medicine without scar left and pain and its compounding process |
| 02/20/2002 | CN1336228A External-use burn and scald treating medicine and its prepn. process |
| 02/20/2002 | CN1336204A Health-care products for oral or external use |
| 02/20/2002 | CN1336203A Composite medicine for treating burns and its prepn. method |
| 02/20/2002 | CN1336202A Ointment specially for treating dermatosis |
| 02/20/2002 | CN1336198A Qinggangdan Lotion for washing feet to treat Hongkong foot |
| 02/20/2002 | CN1336191A Radiation-resisting functional water containing natural medicine component and its compounding process |
| 02/20/2002 | CN1336181A Chinese medicine ointment for promoting epidermization |
| 02/20/2002 | CN1336177A Prepn. of polyvinylpyrrolidone ointment |
| 02/20/2002 | CN1336167A 3-substituted-flavylium salt compound composition for coloring human skin, and its applications |
| 02/20/2002 | CN1079390C Propynyl or dienyl diaromatic compounds |
| 02/20/2002 | CN1079257C Medicine powder for treating burn and empyrosis |
| 02/20/2002 | CN1079254C Extract for treating sore and carbuncle |
| 02/19/2002 | US6348609 Method for obtaining an oil that is rich in hydroxyoctadecadienoic fatty acids (HODE) or the esters thereof from a mixture containing linoleic acid or the esters thereof |
| 02/19/2002 | US6348602 Cyclic AMP-specific phosphodiesterase inhibitors |
| 02/19/2002 | US6348487 2-phenyl benzimidazole derivatives as MCP-1 antagonists |
| 02/19/2002 | US6348463 Phenylalanine derivatives |
| 02/19/2002 | US6348459 Sultam and sultone derived oxazolidinones |
| 02/19/2002 | US6348455 Compound for treatment of psychosis |
| 02/19/2002 | US6348351 Tie receptor tyrosine kinase ligand homologues |
| 02/19/2002 | US6348329 Isolation of polynucleotide sequence codes of polypeptide with amino acid sequences |
| 02/19/2002 | US6348214 Materials and methods for making improved liposome compositions |
| 02/19/2002 | US6348205 And carbon dioxide, hydrates and reduces the transepidermal water loss in dry skin, treating atopic dermatitis (neurodermatitis). |
| 02/19/2002 | US6348204 Cosmetic or dermatological composition containing at least one extract of mulberry, at least one extract of skullcap and at least one salicylic acid derivative |
| 02/19/2002 | CA2182030C Use of a bradykinin antagonist in a cosmetic, pharmaceutical or dermatological composition; composition thus obtained |
| 02/19/2002 | CA2165118C Cosmetic or dermatologic composition containing a ceramide mixture; use thereof for skin moisturizing |
| 02/14/2002 | WO2002012501A2 Anti-dual integrin antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012500A2 Anti-il-12 antibodies, compositions, methods and uses |
| 02/14/2002 | WO2002012495A1 Protein induced by homogeneous blood transfusion and dna encoding the same |
| 02/14/2002 | WO2002012340A2 Transporters and ion channels |
| 02/14/2002 | WO2002012258A1 New immunoeffector compounds |
| 02/14/2002 | WO2002012250A2 Pyrazole-thiazole compounds, pharmaceutical compositions containing them, and methods of their use for inhibiting cyclin-dependent kinases |
| 02/14/2002 | WO2002012242A2 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 02/14/2002 | WO2002012239A1 Benzimidazole derivatives, preparation and therapeutic use thereof |
| 02/14/2002 | WO2002012238A2 2-(4-PYRIDYL)AMINO-6-DIALKOXYPHENYL-PYRIDO[2,3-d]PYRIMIDIN-7-ONES |
| 02/14/2002 | WO2002012235A1 1,4-dihydropyridines as bradykinin antagonists |
| 02/14/2002 | WO2002012228A1 Cinnoline compounds |
| 02/14/2002 | WO2002012227A2 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012226A1 Quinoline derivatives having vegf inhibiting activity |
| 02/14/2002 | WO2002012210A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | WO2002012199A1 Heterocyclic mutilin esters and their use as antibacterials |
| 02/14/2002 | WO2002012196A2 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | WO2002012168A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 02/14/2002 | WO2002011779A1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter |
| 02/14/2002 | WO2002011769A1 Vascular endothelial growth factor 2 |
| 02/14/2002 | WO2002011767A2 Methods for treating autoimmune and chronic inflammatory conditions using antagonists of cd30 or cd30l |
| 02/14/2002 | WO2002011763A1 Cd40 antagonists for use in treating psoriasis and other inflammatory skin conditions |
| 02/14/2002 | WO2002011747A2 Transglutaminase for inhibiting angiogenesis |
| 02/14/2002 | WO2002011738A1 Cosmetics or dermatological preparations containing polymers having phosphorylcholine side chain |
| 02/14/2002 | WO2002011718A1 IgE PRODUCTION INHIBITORS |
| 02/14/2002 | WO2002011715A2 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/14/2002 | WO2002011698A1 Novel compositions of minoxidil |
| 02/14/2002 | WO2002011697A1 A method of preparing a pharmaceutical composition |
| 02/14/2002 | WO2002011683A1 Topical gel delivery system |
| 02/14/2002 | WO2002011677A2 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 02/14/2002 | WO2001081415A9 Parathyroid hormone and parathyroid hormone-related protein antagonists |
| 02/14/2002 | WO2001072328A3 Methods of treating diseases with activated protein c |
| 02/14/2002 | WO2001056598A3 Methods for preventing or attenuating pathoangiogenic conditions by using gbs-toxin (cm101) |
| 02/14/2002 | WO2001055092A3 5-aminolevulinic acid formulation dissolved/dispersed in non-aqueous solvents |
| 02/14/2002 | WO2001051619A3 Genetically modified fibroblast cell |
| 02/14/2002 | WO2001049685A3 Sulfonamides and derivatives thereof that modulate the activity of endothelin |
| 02/14/2002 | WO2001049252A3 Oil-in-water type cosmetic or dermatological preparations |
| 02/14/2002 | WO2001042288A3 G-protein coupled receptors |
| 02/14/2002 | US20020019563 A S-(2-(1-iminoethyl)amino)ethyl)-2-methyl-L-cysteine |
| 02/14/2002 | US20020019547 Skin disorders; reacting retinol with chloroformate compound |
| 02/14/2002 | US20020019534 Gem substituted hydroxamic acids |
| 02/14/2002 | US20020019533 Piperidine derivatives and anti-platelet agents containing the same |
| 02/14/2002 | US20020019530 Antitumor agent |
| 02/14/2002 | US20020019526 Pyrrolo[2,3-d]pyrimidine compounds |
| 02/14/2002 | US20020019515 Novel spoIIIE |
| 02/14/2002 | US20020019425 Anticancer agents; administering p53 gene or protein |
| 02/14/2002 | US20020019414 N-aryl(thio)anthranilic acid amide derivatives, their preparation and their use as VEGF receptor tyrosine kinase inhibitors |
| 02/14/2002 | US20020019409 Treating allergic and inflammatory conditions |
| 02/14/2002 | US20020019404 Anticancer agents, skin disorders |
| 02/14/2002 | US20020019402 Integrin inhibitors and their methods of use |
| 02/14/2002 | US20020019393 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain |
| 02/14/2002 | US20020019354 Method of treatment of seborrheic dermatitis |
| 02/14/2002 | US20020019346 Treatment of prostate cancer by inhibiting lyn tyrosine kinase |
| 02/14/2002 | US20020019341 Modulation of systemic memory T cell trafficking |
| 02/14/2002 | US20020019000 Polynucleotides coexpressed with matrix-remodeling genes |
| 02/14/2002 | US20020018787 Synergistic mixture of dimethylglycine and mussel extract |
| 02/14/2002 | US20020018758 Polyethersiloxane copolymer graft polymer |
| 02/14/2002 | US20020018757 Controlling, reducing oily skins; topical applying |
| 02/14/2002 | DE10035991A1 Nagellackzusammensetzung Nail polish composition |
| 02/14/2002 | CA2418995A1 Lactam compounds and their use as inhibitors of serine proteases and method |
| 02/14/2002 | CA2418946A1 Pharmaceutical form comprising a cell regulating factor and/or a cell proliferation promoter |
| 02/14/2002 | CA2418895A1 Biphenyl derivatives and their use as ppar-gamma receptor activators |
| 02/14/2002 | CA2418083A1 Treatment of hyperproliferative diseases with epidermal growth factor receptor antagonists |
| 02/14/2002 | CA2417587A1 Transporters and ion channels |
| 02/14/2002 | CA2417098A1 The use of benzylideneaminoguanidines and hydroxyguanidines as melanocortin receptor ligands |
| 02/14/2002 | CA2416525A1 Indole, azaindole and indazole derivatives having vegf inhibiting activity |
| 02/14/2002 | CA2415469A1 Quinoline derivatives having vegf inhibiting activity |
| 02/14/2002 | CA2415467A1 Novel n-(2-phenyl-3-aminopropyl)naphtamides |
| 02/14/2002 | CA2415022A1 Cinnoline compounds |